A plaque hybridization assay for quantifying and cloning infectious human immunodeficiency virus type 1 virions

Journal of Virological Methods

Volumn 72, Issue 1, 1998, Pages 1-7

  Kato, S ^a   Hiraishi, Y ^a   Nishimura, N ^a,b   Sugita, T ^a   Tomihama, M ^a,c   Takano, T ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIMADZU CORPORATION   (Japan)

^c Kaihou Hospital   (Japan)

Author keywords

HIV 1; Infectious virion; Plaque hybridization; Quantitation

Indexed keywords

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; VIRUS CELL INTERACTION; VIRUS CULTURE;

CELL LINE, TRANSFORMED; CELLS, CULTURED; HIV INFECTIONS; HIV-1; HUMANS; LINEAR MODELS; NUCLEIC ACID HYBRIDIZATION; PLAQUE ASSAY; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031840868     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00007-X     Document Type: Article

References (22)

1. Adachi, A., Gendelman, H.E., Koenig, S., Folks, T., Willey, R., Rabson, A., Martin, M.A., 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291.
2. Chesebro, B., Wehrly, K., 1988. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J. Virol. 62, 3779-3788.
3. Chesebro, B., Wehrly, K., Metcalf, J., Griffin, D.E., 1991. Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients. J. Infect. Dis. 163, 64-70.
4. Dulbecco, R., 1988. The nature of viruses. In Dulbecco, R., Ginsberg, H.S. (Eds.), Virology, 2nd ed. Lippincott, Philadelphia, pp. 1-26.
5. Feinberg, A.P., Vogelstein, B., 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13.
6. Fenyö, E.M., Morfeldt-Månson, L., Chiodi, F., Lind, B., von Gegerfelt, A., Albert, J., Olausson, E., Åsjö, B., 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62, 4414-4419.
7. Gilliland, G., Perrin, S., Blanchard, K., Bunn, H.F., 1990. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87, 2725-2729.
8. Harada, S., Koyanagi, Y., Yamamoto, N., 1985. Infection of HTLV-III/LAV in HTLV-1-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229, 563-566.
9. Higuchi, R., 1990. Recombinant PCR. In Innis, M.A., Gelfand, D.H., Sninsky, J.J., White, T.J. (Eds.), PCR Protocols. Academy Press, San Diego, pp. 177-183.
10. Kato, S., Tachibana, K., Takayama, N., Kataoka, H., Yoshida, M.C., Takano, T., 1991. Genetic recombination in a chromosomal translocation t(2;8)(p11;q24) of a Burkitt's lymphoma cell line, KOBK101. Gene 97, 239-244.
11. The Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases), Lathey, J.L., Fiscus, S.A., Rasheed, S., Kappes, J.C., Griffith, B.P., Elbeik, T., Spector, S.A., Reichelderfer, P.S., 1994. Optimization of quantitative culture assay for human immunodeficiency virus from plasma. J. Clin. Microbiol. 32, 3064-3067.
12. Layne, S.P., Merges, M.J., Dembo, M., Spouge, J.L., Conley, S.R., Moore, J.P., Raina, J.L., Renz, H., Gelderblom, H.R., Nara, P.L., 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189, 695-714.
13. Levy, J.A., Hoffman, A.D., Kramer, S.M., Landis, J.A., Shimabukuro, J.M., Oshiro, L.S., 1984. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225, 840-842.
14. Matsui, T., Nakashima, H., Yoshiyama, H., Kobayashi, N., Yamamoto, N., 1987. Plaque staining assay for non- or weakly cytotoxic human immunodeficiency virus. J. Clin. Microbiol. 25, 1305-1307.
15. McDougal, J.S., Cort, S.P., Kennedy, M.S., Cabridilla, C.D., Feorino, P.M., Francis, D.P., Hicks, D., Kalyanaraman, V.S., Martin, L.S., 1985. Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). J. Immunol. Methods 76, 171-183.
16. McKeating, J.A., McKnight, A., Moore, J.P., 1991. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J. Virol. 65, 852-860.
17. Nakashima, H., Pauwels, R., Baba, M., Schols, D., Desmyter, J., De Clercq, E., 1989. Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds. J. Virol. Methods 26, 319-330.
18. Nara, P.L., Fischinger, P.J., 1988. Quantitative infectivity assay for HIV-1 and -2. Nature 332, 469-470.
19. Nara, P.L., Hatch, W.C., Dunlop, N.M., Robey, W.G., Arthur, L.O., Gonda, M.A., Fischinger, P.J., 1987. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. Hum. Retroviruses 3, 283-302.
20. Popovic, M., Sarngadharan, M.G., Read, E., Gallo, R.C., 1984. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497-500.
21. Reed, L.J., Muench, H., 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493-497.
22. Stieger, M., Demolliere, C., Ahlborn-Laake, L., Mous, J., 1991. Competitive polymerase chain reaction assay for quantitation of HIV-1 DNA and RNA. J. Virol. Methods 34, 149-160.